Therapeutic compositions that alter the immune response

Details for Australian Patent Application No. 2002335932 (hide)

Owner AltaRex Medical Corp.

Inventors Schultes, Birgit C.; Nicodemus, Christopher F.

Agent Shelston IP

Pub. Number AU-B-2002335932

PCT Number PCT/US02/07272

PCT Pub. Number WO2002/076384

Priority 60/277,599 21.03.01 US

Filing date 8 March 2002

Wipo publication date 8 October 2002

Acceptance publication date 1 November 2007

International Classifications

A61P 35/00 (2006.01) Antineoplastic agents

C07K 16/30 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C07K 16/42 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies - against immunoglobulins (anti-idiotypic antibodies)

Event Publications

20 February 2003 Complete Application Filed

  Priority application(s): 60/277,599 21.03.01 US

27 March 2003 Application Open to Public Inspection

  Published as AU-B-2002335932

20 May 2004 Assignment before Grant

  Altarex Corp. The application has been assigned to AltaRex Medical Corp. 2003

1 November 2007 Application Accepted

  Published as AU-B-2002335932

6 March 2008 Standard Patent Sealed

7 October 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002335933-WAVELET BASED FRAUD DETECTION SYSTEM

2002335931-Internal combustion engine with harmonic synchroniser system